Revive Therapeutics Ltd. (OTCMKTS: RVVTF) has announced that it has been included in the initial launch of actively managed ETFs sponsor AdvisorShares Investment LLC’s AdvisorShares Psychedelics ETF (PSIL).
Compound Psilocybin
Visit article
Category Press Release
Country Canada
Companies Featured
Revive TherapeuticsRevive Therapeutics is a life sciences company that aims to develop psychedelics and cannabinoids for rare disorders and infectious diseases.